Consultation opens for Tasmania’s Public Health Amendment Bill 2026

Feb.06
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.

 

Key Takeaways (4–5 bullets)

 

 

  • Consultation opened on February 6, 2026; submissions close on March 6, 2026
  • Bill: Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026
  • Focus: illicit tobacco, nicotine pouches and e-cigarettes
  • Proposed law changes: amendments to the Public Health Act 1997
  • Feedback sought from the Tasmanian community, particularly businesses and health advocates

 


 

2Firsts, February 6, 2026 

 

According to the Tasmanian Department of Health (health.tas.gov.au), consultation opened today for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026 (the Bill).

 

The notice says the Bill intends to address the trade of illicit tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years.

 

It adds that the Bill proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and will also strengthen existing tobacco control laws.

 

Feedback is now being sought from the Tasmanian community, particularly from businesses and health advocates. The draft Bill is available, and feedback can be provided to the Department via email by March 6, 2026.

 

Image Source: Tasmanian Department of Health (health.tas.gov.au)

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
Michigan Proposes 57% Vape Tax in $800M Revenue Plan
Michigan Proposes 57% Vape Tax in $800M Revenue Plan
Michigan Governor Gretchen Whitmer’s FY2027 executive budget proposes a new 57% wholesale tax on vaping products and oral nicotine items as part of a broader $800 million revenue package aimed at stabilizing Medicaid funding.
Regulations
Feb.23
WHO warns Europe will remain the world’s biggest tobacco consumer by 2030 as vaping fuels youth uptake
WHO warns Europe will remain the world’s biggest tobacco consumer by 2030 as vaping fuels youth uptake
According to Euronews, the World Health Organization (WHO) says its European Region—53 countries across Europe and Central Asia—is projected to remain the world’s largest tobacco consumer by 2030. While overall tobacco use is declining, e-cigarettes and flavoured nicotine products are capturing a new generation.
Feb.27 by 2FIRSTS.ai
Puerto Rico House Files P.C. 1070 to Ban Flavored Vaping Product Sales to Under-21s
Puerto Rico House Files P.C. 1070 to Ban Flavored Vaping Product Sales to Under-21s
According to a statement from the Puerto Rico House of Representatives, House Speaker Carlos Méndez and Rep. Pedro Julio Santiago announced the filing of House Bill 1070 (P.C. 1070), which would prohibit sales to people under 21 of vaping devices, liquids, or cartridges featuring a flavor and/or aroma other than nicotine.
Jan.29 by 2FIRSTS.ai
Denver’s Flavored Tobacco Ban Faces Constitutional Challenge From Vape Trade Group
Denver’s Flavored Tobacco Ban Faces Constitutional Challenge From Vape Trade Group
A Colorado vape industry trade group says Denver’s voter-approved flavored tobacco sales ban is unconstitutional and too vague to enforce. The group is asking a state court for a permanent injunction blocking enforcement of Ordinance 24-1765 and for a declaration allowing flavored tobacco and vape sales, citing state constitutional vagueness concerns and multiple U.S. constitutional issues.
Jan.27 by 2FIRSTS.ai
KT&G’s Heated Tobacco Brand “lil” Named to Korea’s Brand Hall of Fame for Eighth Consecutive Year
KT&G’s Heated Tobacco Brand “lil” Named to Korea’s Brand Hall of Fame for Eighth Consecutive Year
KT&G said its heated tobacco brand “lil” was selected as an outstanding brand in the heated tobacco category of the “2026 Korea Brand Hall of Fame,” marking its eighth straight year on the list. The awards are organized by the Industrial Policy Research Institute (IPS) and determined through a composite evaluation of customer satisfaction, brand value and market performance.
Jan.26 by 2FIRSTS.ai